Stockreport

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA) has been executed to advance the development of camon [Read more]